AIM
AIM ImmunoTech Inc.
Key Financials
Operating Income
$-11664000
↑ 41.0%
Net Income
$-13958000
↑ 19.4%
Revenue
$88000
↓ 48.2%
Total Assets
$5.8M
↓ 32.8%
Shareholders' Equity
$-9783000.00
↓ 640.0%
Total Liabilities
$15.6M
↑ 56.7%
EPS (Diluted)
$-8.62
↓ 2680.6%
Cash & Equivalents
$3.0M
↑ 75.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| ARS | 9/30/2026 | View on SEC |
| DEF 14A | 9/30/2026 | View on SEC |
| 4 | 9/18/2026 | View on SEC |
| 4 | 9/17/2026 | View on SEC |
| 4 | 9/16/2026 | View on SEC |
| 4 | 9/15/2026 | View on SEC |
| 8-K | 9/14/2026 | View on SEC |
| 8-K | 9/10/2026 | View on SEC |
| 8-K | 9/4/2026 | View on SEC |
| 8-K | 8/11/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AIM |
| Company Name | AIM ImmunoTech Inc. |
| CIK | 946644 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | NYSE |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 352-448-7797 |